Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancer

Vitaly Margulis, Yair Lotan, Pierre I. Karakiewicz, Yves Fradet, Raheela Ashfaq, Umberto Capitanio, Francesco Montorsi, Patrick J. Bastian, Matthew E. Nielsen, Stefan C. Müller, Jérôme Rigaud, Lukas C. Heukamp, George Netto, Seth P. Lerner, Arthur I Sagalowsky, Shahrokh F. Shariat

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Several small single-center studies have reported a prognostic role for Ki-67 labeling index in advanced urothelial carcinoma of the urinary bladder. To investigate whether Ki-67 was a useful biomarker of oncological outcome after radical cystectomy for urothelial carcinoma, we assessed its expression in tumor tissue from 713 patients treated with radical cystectomy and bilateral lymphadenectomy at six centers. A high Ki-67 labeling index was independently associated with established features of aggressive urothelial carcinoma, disease recurrence, and cancer-specific survival. Addition of Ki-67 labeling index improved the accuracy of standard multivariate outcome prediction models, as measured by Harrell concordance index, by 2.9% for disease recurrence and 2.4% for bladder cancer-specific survival (P <. 001, two-sided Mantel-Haenszel) - a statistically and potentially clinically significant margin. In conclusion, routine assessment of Ki-67 expression status along with assessment of other established predictors of urothelial carcinoma outcome has the potential to improve identification of patients who are at increased risk for disease progression after radical cystectomy and thus may benefit from perioperative systemic chemotherapy.

Original languageEnglish (US)
Pages (from-to)114-119
Number of pages6
JournalJournal of the National Cancer Institute
Volume101
Issue number2
DOIs
StatePublished - Jan 2009

Fingerprint

Urinary Bladder Neoplasms
Cystectomy
Carcinoma
Recurrence
Survival
Lymph Node Excision
Disease Progression
Neoplasms
Urinary Bladder
Biomarkers
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancer. / Margulis, Vitaly; Lotan, Yair; Karakiewicz, Pierre I.; Fradet, Yves; Ashfaq, Raheela; Capitanio, Umberto; Montorsi, Francesco; Bastian, Patrick J.; Nielsen, Matthew E.; Müller, Stefan C.; Rigaud, Jérôme; Heukamp, Lukas C.; Netto, George; Lerner, Seth P.; Sagalowsky, Arthur I; Shariat, Shahrokh F.

In: Journal of the National Cancer Institute, Vol. 101, No. 2, 01.2009, p. 114-119.

Research output: Contribution to journalArticle

Margulis, V, Lotan, Y, Karakiewicz, PI, Fradet, Y, Ashfaq, R, Capitanio, U, Montorsi, F, Bastian, PJ, Nielsen, ME, Müller, SC, Rigaud, J, Heukamp, LC, Netto, G, Lerner, SP, Sagalowsky, AI & Shariat, SF 2009, 'Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancer', Journal of the National Cancer Institute, vol. 101, no. 2, pp. 114-119. https://doi.org/10.1093/jnci/djn451
Margulis, Vitaly ; Lotan, Yair ; Karakiewicz, Pierre I. ; Fradet, Yves ; Ashfaq, Raheela ; Capitanio, Umberto ; Montorsi, Francesco ; Bastian, Patrick J. ; Nielsen, Matthew E. ; Müller, Stefan C. ; Rigaud, Jérôme ; Heukamp, Lukas C. ; Netto, George ; Lerner, Seth P. ; Sagalowsky, Arthur I ; Shariat, Shahrokh F. / Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancer. In: Journal of the National Cancer Institute. 2009 ; Vol. 101, No. 2. pp. 114-119.
@article{fd68a20b5b7f48dda9adcbb7240b8559,
title = "Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancer",
abstract = "Several small single-center studies have reported a prognostic role for Ki-67 labeling index in advanced urothelial carcinoma of the urinary bladder. To investigate whether Ki-67 was a useful biomarker of oncological outcome after radical cystectomy for urothelial carcinoma, we assessed its expression in tumor tissue from 713 patients treated with radical cystectomy and bilateral lymphadenectomy at six centers. A high Ki-67 labeling index was independently associated with established features of aggressive urothelial carcinoma, disease recurrence, and cancer-specific survival. Addition of Ki-67 labeling index improved the accuracy of standard multivariate outcome prediction models, as measured by Harrell concordance index, by 2.9{\%} for disease recurrence and 2.4{\%} for bladder cancer-specific survival (P <. 001, two-sided Mantel-Haenszel) - a statistically and potentially clinically significant margin. In conclusion, routine assessment of Ki-67 expression status along with assessment of other established predictors of urothelial carcinoma outcome has the potential to improve identification of patients who are at increased risk for disease progression after radical cystectomy and thus may benefit from perioperative systemic chemotherapy.",
author = "Vitaly Margulis and Yair Lotan and Karakiewicz, {Pierre I.} and Yves Fradet and Raheela Ashfaq and Umberto Capitanio and Francesco Montorsi and Bastian, {Patrick J.} and Nielsen, {Matthew E.} and M{\"u}ller, {Stefan C.} and J{\'e}r{\^o}me Rigaud and Heukamp, {Lukas C.} and George Netto and Lerner, {Seth P.} and Sagalowsky, {Arthur I} and Shariat, {Shahrokh F.}",
year = "2009",
month = "1",
doi = "10.1093/jnci/djn451",
language = "English (US)",
volume = "101",
pages = "114--119",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancer

AU - Margulis, Vitaly

AU - Lotan, Yair

AU - Karakiewicz, Pierre I.

AU - Fradet, Yves

AU - Ashfaq, Raheela

AU - Capitanio, Umberto

AU - Montorsi, Francesco

AU - Bastian, Patrick J.

AU - Nielsen, Matthew E.

AU - Müller, Stefan C.

AU - Rigaud, Jérôme

AU - Heukamp, Lukas C.

AU - Netto, George

AU - Lerner, Seth P.

AU - Sagalowsky, Arthur I

AU - Shariat, Shahrokh F.

PY - 2009/1

Y1 - 2009/1

N2 - Several small single-center studies have reported a prognostic role for Ki-67 labeling index in advanced urothelial carcinoma of the urinary bladder. To investigate whether Ki-67 was a useful biomarker of oncological outcome after radical cystectomy for urothelial carcinoma, we assessed its expression in tumor tissue from 713 patients treated with radical cystectomy and bilateral lymphadenectomy at six centers. A high Ki-67 labeling index was independently associated with established features of aggressive urothelial carcinoma, disease recurrence, and cancer-specific survival. Addition of Ki-67 labeling index improved the accuracy of standard multivariate outcome prediction models, as measured by Harrell concordance index, by 2.9% for disease recurrence and 2.4% for bladder cancer-specific survival (P <. 001, two-sided Mantel-Haenszel) - a statistically and potentially clinically significant margin. In conclusion, routine assessment of Ki-67 expression status along with assessment of other established predictors of urothelial carcinoma outcome has the potential to improve identification of patients who are at increased risk for disease progression after radical cystectomy and thus may benefit from perioperative systemic chemotherapy.

AB - Several small single-center studies have reported a prognostic role for Ki-67 labeling index in advanced urothelial carcinoma of the urinary bladder. To investigate whether Ki-67 was a useful biomarker of oncological outcome after radical cystectomy for urothelial carcinoma, we assessed its expression in tumor tissue from 713 patients treated with radical cystectomy and bilateral lymphadenectomy at six centers. A high Ki-67 labeling index was independently associated with established features of aggressive urothelial carcinoma, disease recurrence, and cancer-specific survival. Addition of Ki-67 labeling index improved the accuracy of standard multivariate outcome prediction models, as measured by Harrell concordance index, by 2.9% for disease recurrence and 2.4% for bladder cancer-specific survival (P <. 001, two-sided Mantel-Haenszel) - a statistically and potentially clinically significant margin. In conclusion, routine assessment of Ki-67 expression status along with assessment of other established predictors of urothelial carcinoma outcome has the potential to improve identification of patients who are at increased risk for disease progression after radical cystectomy and thus may benefit from perioperative systemic chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=59049085842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59049085842&partnerID=8YFLogxK

U2 - 10.1093/jnci/djn451

DO - 10.1093/jnci/djn451

M3 - Article

C2 - 19141773

AN - SCOPUS:59049085842

VL - 101

SP - 114

EP - 119

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 2

ER -